4//SEC Filing
Elsbree David B 4
Accession 0000899243-22-000454
CIK 0001492674other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 3:57 PM ET
Size
7.9 KB
Accession
0000899243-22-000454
Insider Transaction Report
Form 4
Elsbree David B
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-01-01+32,258→ 0 total→ Common Stock (32,258 underlying) - Exercise/Conversion
Common Stock
2022-01-01+32,258→ 202,981 total
Holdings
- 10,000(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F3]On January 1, 2021 the reporting person was granted 32,258 restricted stock units that vested on January 1, 2022.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001292650
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 3:57 PM ET
- Size
- 7.9 KB